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Review question
To undertake an umbrella review of systematic reviews and meta-analyses of observational and
interventional studies investigating the role of hormone replacement therapy in the primary and secondary
prevention of multiple health and disease outcomes in menopausal women.
 
Searches
We will search MEDLINE, EMBASE, Cochrane Library, Cochrane Database of Systematic Reviews,
Database of Abstracts of Reviews of Effects (DARE), ISI Web of Science, CINAHL, Google Scholar, AMED,
PsycINFO, CAB International, and WHO Global Health Library. The databases will be searched for studies
published from inception until year 2017.  Additional references will be manually located through searching
the references cited in identified studies; and contacting international experts in the field. We will use the
following keywords and MeSH headings to identify eligible studies: (“hormone replacement therapy" OR
"hormone therapy" OR "estrogen therapy" OR "estrogen-progestin therapy" OR "combined hormone
therapy”) AND (“systematic review” OR “meta-analysis”).
 
Types of study to be included
We will include all systematic reviews and meta-analyses of analytical epidemiological studies and clinical
trials
 
Condition or domain being studied
Any health or disease outcome: for example neoplasm, cardiovascular conditions, mortality, respiratory,
metabolic, and allergic outcomes, and symptoms of menopause.
 
Participants/population
We will include all systematic reviews and meta-analyses of analytical epidemiological studies and clinical
trials that have investigated the associations and effect of hormone replacement therapy given for
perimenopausal, menopausal and postmenopausal women on any disease outcome or health indicator in
women, including symptoms resulting from menopause. We will include only human studies in which authors
performed a systematic search to identify studies. There will be no language restriction and will translate any
study not published in English language. We will exclude meta-analyses lacking sufficient data from
individual studies, such as relative risks, 95% confidence intervals, number of cases and controls, or total
population. If more than one systematic review/meta-analysis exists for the same exposure/intervention-
outcome relationship, we will select the study with the largest number of studies in order to avoid any
duplication. For observational studies, we will focus on cohort studies as these are considered the strongest
study designs within observational evidence in judging the strength of cause-effect relationships. However,
for studies with case-control design, we will undertake sensitivity analyses to evaluate their influence on the
effect estimates and overall conclusion.
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Intervention(s), exposure(s)
Hormone replacement therapy prescribed for perimenopausal, menopausal and postmenopausal women
 
Comparator(s)/control
No hormone replacement therapy
 
Primary outcome(s)
Any chronic condition subjectively or objectively measured
 
Secondary outcome(s)
All non-chronic conditions subjectively or objectively measured 
Data extraction (selection and coding)
The papers retrieved from the databases will be exported to a relevant literature management platform and
will be independently screened by at least two members of the project team. First stage of screening will be
at the level of article titles and abstracts. Full text of papers potentially meeting the eligibility criteria at this
stage will be further independently screened by at least two team members. Any discrepancies in the
screening process will be resolved by discussion or arbitrated by at least one of the team members. We will
use a customized data extraction form to retrieve relevant data from included studies: from systematic
reviews/meta-analyses, we will extract the name of the first author, year of publication, outcomes,
exposure/intervention, and number of studies included. From the primary studies included in a systematic
review/meta-analysis, we will extract the name of the first author, year of publication, study design, number
of cases and controls for case-control studies, events and participants/person-years of follow-up  for cohort
studies, and numbers in intervention and control groups in clinical trials, type of risk estimates used in meta-
analysis, effect estimates and their corresponding 95% confidence intervals, and type of meta-analysis
model (fixed or random effects). Any discrepancies in data extraction and quality appraisal will be resolved
by discussion or arbitrated by at least one of the team members.
 
Risk of bias (quality) assessment
We will use the AMSTAR (Assessing the Methodological Quality of Systematic Reviews) tool to appraise the
quality of included studies.
 
Strategy for data synthesis
For the association between HRT (or effect on) and specific outcomes, we will compute the effect estimates
and their corresponding 95% confidence intervals using fixed and random effects approaches, depending on
the assumption made on each specific estimate. We will evaluate heterogeneity between studies by using
Cochran’s Q test and the I² statistic. We will also estimate the 95% prediction interval, which takes into
account the overall uncertainty surrounding the summary effect and heterogeneity across studies to provide
a range for which we are 95% confident that the effect of HRT on specific outcomes in new studies would lie.
We will evaluate small study effect (as an indication of publication bias) by plotting funnel plots and
computing the Egger’s regression asymmetry test. We will assess excess significance bias and calculate
the credibility ceilings, which provides sensitivity evaluation of the results by accounting for possible
methodological limitations of observational studies.
 
Analysis of subgroups or subsets
We will evaluate the role of different types of HRT (estrogen vs estrogen-progestin hormone therapies).
Where possible, we will stratify the analyses by age of women (e.g. younger  women < 55 years vs older
women ?55 years), and by menopausal status (perimenopausal, menopausal, postmenopausal). We will
also analyze the data with regards to the effect of HRT for primary prevention vs secondary prevention of
outcomes in women.
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Contact details for further information
Dr Siew Hwa Lee
s.h.lee1@rgu.ac.uk
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Robert Gordon University, Aberdeen, Scotland, UK
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Details of any existing review of the same topic by the same authors
 
Stage of review at time of this submission
 
Stage Started Completed
Preliminary searches Yes Yes
Piloting of the study selection process Yes No
Formal screening of search results against eligibility criteria Yes No
Data extraction No No
Risk of bias (quality) assessment No No
Data analysis No No
 
Versions
 
18 December 2017
PROSPERO
This information has been provided by the named contact for this review. CRD has accepted this information in good
faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration
record, any associated files or external websites. 
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